Cancer Article Comments on ASCO’s Updated Guidelines for Integrating Palliative Care
ASCO’s updated guidelines emphasize integrating palliative care into oncology, highlighting challenges in workforce and equitable access.
Related Articles
Real-World Data Confirm Apalutamide Benefit in mHSPC Diagnosed by Conventional Imaging | GU Oncology Now
Data from a real-world study have shown that apalutamide can boost radiographic progression-free survival and overall survival in patients with mHSPC.
Association of low vitamin C concentrations and low consumption of fresh fruit and vegetables with cardiovascular disease in type 2 diabetes – BMC Nutrition
Purpose Vitamin C is a fundamental antioxidant with important metabolic actions in several biological processes. Patients with type 2 diabetes (T2D) are exposed to oxidative…
New Evidence Links Microplastics with Chronic Disease – American College of Cardiology
Contact: Nicole Napoli, nnapoli@acc.org, Tiny fragments of plastic have become ubiquitous in our environment and our bodies. Higher exposure to these microplastics, which can be…
Myocardial Infarction and Cardiovascular Risks Associated with Cannabis Use: A Multicenter Retrospective Study:
Internal Medicine Department, Boston Medical Center, Boston University School of Medicine, Massachusetts Internal Medicine Department, Boston Medical Center, Boston University School of Medicine, Massachusetts Cardiovascular…
Here’s why 90% of Americans don’t sleep through the night
Sleep is of great importance to overall health, but many people struggle to get quality slumber.
Smoothies with seeds may improve glycemic control, study shows
Blending whole fruits into smoothies may reduce glycemic spikes compared to eating fruit whole or drinking juice, especially when seeds are included. Researchers urge a…
In Print | Blood Cancers Today
Blood Cancers Today’s publication provides hematologist oncologists with news, education, and information relevant to their patients and practices.
FDA Grants Orphan Drug Designation to Bexobrutideg for Waldenström Macroglobulinemia | Docwire News
Bexobrutideg, an orally bioavailable, brain-penetrant BTK degrader, is being evaluated in a dose-escalation (phase 1a) and cohort-expansion (phase 1b) study.
ORCHARD: Osimertinib Plus Datopotamab Deruxtecan Shows ‘Promising’ Efficacy in NSCLC
Osimertinib plus datopotamab deruxtecan showed “promising efficacy and manageable safety” in patients with EGFR-mutated advanced non-small cell lung cancer (NSCLC).
The Cancer Nursing Today CARE Award | Cancer Nursing Today
Nurses: Nominate your oncology nursing peers and colleagues who demonstrate resilience, role modeling, and high-level patient care for the inagural CNT CARE Award.
